Global Molecular Cytogenetics Market 2014-2018 -





Published: June 2014 | Pages: 96 | Format: PDF

 About Molecular Cytogenetics 

 Molecular Cytogenetics involves the study of chromosomes using molecular biology to understand the role and functions of genes and chromosomes. It plays a crucial role in the early diagnosis of a disease, identification of genetic tendency to cause disease, and prediction of an individual's reaction to drugs. The FISH and aCGH play a prominent role in molecular cytogenetics technology.  It involves the screening and diagnostic tests that are used for determining the complex interaction of genes and chromosomes to assess the status of a disease. In addition, molecular cytogenetics is mainly used in the R&D activities of research laboratories for drug discovery, identification of biomarkers, and screening drug candidates that react to these biomarkers. 

 TechNavio's analysts forecast the Global Molecular Cytogenetics Market will grow at a CAGR of 23.51 percent over the period 2013-2018. 

 Covered in this Report 

 This report covers the present scenario and the growth prospects of the Global Molecular Cytogenetics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used in molecular cytogenetics. The products employed in the use of FISH and aCGH techniques are considered within the scope of the report. 

 TechNavio's report, the Global Molecular Cytogenetics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions with individual country-wise revenue segmentation; it also covers the Global Molecular Cytogenetics market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market. 

 Key Regions 

 

  •  Americas 
  •  EMEA        
  •  APAC 

 

 Key Vendors 

 

  •  Abbott Laboratories 
  •  Affymetrix Inc. 
  •  Agilent Technologies Inc. 
  •  F. Hoffmann-La Roche Ltd 
  •  Illumina Inc. 
  •  PerkinElmer Inc. 

 

 Other Prominent Vendors 

 

  •  Applied Spectral Imaging Ltd 
  •  Biological Industries Ltd 
  •  Bio-Rad Laboratories Inc. 
  •  Cytognomix Inc. 
  •  CytoTest Inc. 
  •  Illumina Inc. 
  •  Kreatech Inc. 
  •  Leica Biosystems Ltd 
  •  Life Technologies Corp. 
  •  Oxford Gene Technology Ltd 
  •  SciGene Corp. 

 

 Key Market Driver 

 

  •  Increasing Incidence of Genetic Disorders. 
  •  For a full, detailed list, view our report. 

 

 Key Market Challenge 

 

  •  Ethical and Social Constraints. 
  •  For a full, detailed list, view our report. 

 

 Key Market Trend 

 

  •  Increased Preference of Personalized Medicine. 
  •  For a full, detailed list, view our report. 

 

 Key Questions Answered in this Report 

 

  •  What will the market size be in 2018 and what will the growth rate be? 
  •  What are the key market trends? 
  •  What is driving this market? 
  •  What are the challenges to market growth? 
  •  Who are the key vendors in this market space? 
  •  What are the market opportunities and threats faced by the key vendors? 
  •  What are the strengths and weaknesses of the key vendors? 

 

 *Fiver User License Available for $2,800.00*

 01.  Executive Summary 

 02. List of Abbreviations 

 03. Scope of the Report 

 03.1 Market Overview 

 03.2 Product Offerings 

 04. Market Research Methodology 

 04.1 Market Research Process 

 04.2 Research Methodology 

 05. Introduction 

 06. Market Landscape 

 06.1 Market Overview 

 06.2 Market Size and Forecast 

 06.3  Five Forces Analysis 

 07. Market Segmentation by Application 

 08. Market Segmentation by Technology 

 09. Geographical Segmentation 

 10. Buying Criteria 

 11. Market Growth Drivers 

 12. Drivers and their Impact 

 13. Market Challenges 

 14. Impact of Drivers and Challenges 

 15. Market Trends 

 16. Trends and their Impact 

 17. Vendor Landscape 

 17.1 Competitive Scenario 

 17.1.1 Key News 

 17.1.2 Mergers , Acquisitions and Partnership 

 17.2 Vendor Analysis 2013 

 17.3 Other Prominent Vendors 

 18. Key Vendor Analysis 

 18.1 Vendor 1 

 18.1.1 Business Overview 

 18.1.2 Business Segmentation 

 18.1.3 Key Information 

 18.1.4 SWOT Analysis 

 19. Other Reports in this Series 

  

 List of Exhibits: 

 Exhibit 1: Market Research Methodology 

 Exhibit 2: Global Molecular Cytogenetics Market 2013-2018 (US$ million) 

 Exhibit 3: Global Molecular Cytogenetics Market Segmentation by Application 

 Exhibit 4: Global Molecular Cytogenetics Market Segmentation Based on Application 2013 

 Exhibit 5: Global Molecular Cytogenetics Market by Technology 

 Exhibit 6: Global Molecular Cytogenetics Market by Geographical Segmentation 2013